Oral mexiletine for ventricular tachyarrhythmias treatment in implantable cardioverter-defibrillator patients: a systematic review of the literature.

Faculty of Medicine

Assiut University

Oral mexiletine for ventricular tachyarrhythmias treatment in implantable cardioverter-defibrillator patients: a systematic review of the literature.

Research Authors
Hussam Ali, Ernesto Cristiano, Pierpaolo Lupo, Sara Foresti, D Turturiello, EM Paganini, R Bessi, AA Farghaly, L Nicolì, R Cappato
Research Date
Research Department
Department of Cardiology
Research Journal
Minerva Cardiology and Angiology
Research Member
Ahmed Abdel-Radi Abdel-Salam Farghali
Research Vol
71(6)
Research Website
https://europepmc.org/article/med/36305779
Research Year
2022
Research_Pages
622-630
Research Abstract

Oral mexiletine provides an adjunctive treatment to manage VTAs and reduces appropriate therapies in ICD patients with moderate efficacy and acceptable safety profiles. These observations await confirmation through randomised clinical trials.